Use of human universally antigenic tetanus toxin T cell epitopes as carriers for human vaccination

Détails

ID Serval
serval:BIB_84361EDD8FC3
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Use of human universally antigenic tetanus toxin T cell epitopes as carriers for human vaccination
Périodique
Journal of Immunology
Auteur⸱e⸱s
Valmori  D., Pessi  A., Bianchi  E., Corradin  G.
ISSN
0022-1767 (Print)
Statut éditorial
Publié
Date de publication
07/1992
Volume
149
Numéro
2
Pages
717-21
Notes
Journal Article
Research Support, Non-U.S. Gov't --- Old month value: Jul 15
Résumé
Synthetic constructs were assembled as multiple Ag peptide systems containing repetitive sequences of Plasmodium falciparum and Plasmodium berghei, the causative agents of human and murine malaria respectively, and two universal human tetanus toxin T cell epitopes 830-843 and 947-967. These constructs were tested for antibody production in mice and for their capacity to stimulate human PBL and tetanus toxin-specific T cell clones. A high antibody titer can be obtained in mice when multiple Ag peptide systems are injected in various adjuvants or in PBS alone. Furthermore, all constructs can activate PBL from every donor tested. However, a variable response was obtained when different clones specific for the two tetanus toxin universal epitopes were used. These constructs may represent possible candidates for a malaria vaccine.
Mots-clé
Amino Acid Sequence Animals *Epitopes Humans Molecular Sequence Data Peptide Fragments/*administration & dosage/immunology Plasmodium berghei/*immunology Plasmodium falciparum/*immunology Protozoan Vaccines/*administration & dosage T-Lymphocytes/*immunology Tetrodotoxin/*administration & dosage/immunology Vaccination
Pubmed
Web of science
Création de la notice
24/01/2008 14:55
Dernière modification de la notice
20/08/2019 14:43
Données d'usage